NCT05128890Recruiting
Evaluation of Resection Techniques for Pancreatic Tumors
Source: ClinicalTrials.gov · Last updated 20 Mar 2026
Brief summary (registry, in English)
The objective of this study is to compare open and minimally invasive pancreatic and liver resection techniques and analyze the different outcome variables from the clinical standpoint. The plan is to investigate patient survival, length of stay, complication rates, operative time, transfusion rate, 30 and 90-day readmission rate, and hospital charges.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 431 (estimated)
- First submitted
- 12 Aug 2019
- Start date
- 16 Apr 2016
- Primary completion date
- 26 Apr 2027
- Lead sponsor
- Methodist Health System
- NCT number
- NCT05128890
What you commit to
- Study type: Observational
- Planned participants: 431
- From 16 Apr 2016 to the primary completion date, 26 Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients that have not undergone pancreatic resection surgeries
Age
- Patients under 18 years of age
Who the study is looking for
- Patients that have undergone pancreatic or liver resection surgeries from January 2006 until December 2020 at Methodist Dallas Medical Center (MDMC)
- Patients 18 years old or older
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Methodist Dallas Medical Center Coordinator of this site? Confirm its status | Dallas | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.